Drug companies weigh ad code

Billy Tauzin, head of the Pharmaceutical Researchers and Manufacturers of America, said drug companies are considering adopting a new code of conduct which would place some limits on the content of industry ads. Tauzin told reporters he thinks new rules could be in place as soon as June or July. According to sources, the proposed code would be modeled after one used by ad agencies. They said the industry will probably rely on an internal review board to review the accuracy and appropriateness of new ads.

- see this story from The New York Times

Post a comment